Lantern Pharma

Fund I Bios LP sold 60,647 shares of LTRN on 12 June. They now own 51,860 LTRN shares, or a 54% holding decrease.

Cavu Advisors LLC sold 60,647 shares of LTRN on 12 June. They now own 51,860 LTRN shares, or a 54% holding decrease.

Fund I Bios LP sold 40,000 shares of LTRN on 13 June. They now own 49,957 LTRN shares, or a 44% holding decrease.

Cavu Advisors LLC sold 40,000 shares of LTRN on 13 June. They now own 49,957 LTRN shares, or a 44% holding decrease.

Fund I Bios LP sold 21,037 shares of LTRN on 27 May. They now own 56,467 LTRN shares, or a 27% holding decrease.

Cavu Advisors LLC sold 21,037 shares of LTRN on 27 May. They now own 56,467 LTRN shares, or a 27% holding decrease.

Fund I Bios LP sold 15,000 shares of LTRN on 28 May. They now own 55,753 LTRN shares, or a 21% holding decrease.

Cavu Advisors LLC sold 15,000 shares of LTRN on 28 May. They now own 55,753 LTRN shares, or a 21% holding decrease.

Fund I Bios LP sold 20,200 shares of LTRN on 29 May. They now own 54,792 LTRN shares, or a 27% holding decrease.

Cavu Advisors LLC sold 20,200 shares of LTRN on 29 May. They now own 54,792 LTRN shares, or a 27% holding decrease.

Cavu Advisors LLC sold 10,000 shares of LTRN on 23 May. They now own 59,326 LTRN shares, or a 14% holding decrease.

Cavu Advisors LLC sold 20,000 shares of LTRN on 24 May. They now own 57,467 LTRN shares, or a 26% holding decrease.

Fund I Bios LP sold 10,000 shares of LTRN on 23 May. They now own 59,326 LTRN shares, or a 14% holding decrease.

Fund I Bios LP sold 20,000 shares of LTRN on 24 May. They now own 57,467 LTRN shares, or a 26% holding decrease.